Sign in
4

Changes in Ownership

Starling Oncology, Inc. Filed Acc 0001628280-23-039815

Director sold 25,000 shares at $2.24 ($56,000)

  • Director acquired 25,000 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Hively Brad Director 2023-11-17 Option exercise +25,000 $0.85 $21,250 722,065 D
Hively Brad Director 2023-11-17 Sale −25,000 $2.24 $56,000 697,065 D
Derivatives
Hively Brad Director 2023-11-17 Option exercise · Non-Qualified Stock Option (right to buy) −25,000 1,745,431 D
Open-market sales · 25,000 sh · avg $2.24 · $56,000
Loading xslF345X05/wk-form4_1700612843.xml…